HONG KONG -- A $13 billion project to turn Hong Kong's airport into a sprawling city-within-a-city could serve as a test case for how much the local business community is willing to spend to show its ...

Samsung said on Friday that operating profit at its semiconductor unit plunged 25.6% to 2.9 trillion won ($2 billion) in the October to December period from a quarter ago. The mobile and network ...

BANGKOK/MANILA/MUMBAI -- U.S. President Donald Trump's push for unfettered free speech on social media and Meta's response to it are sparking concerns of serious safety risks -- even threats to more ...

(Reuters) -- U.S. Steel reported a fourth-quarter loss and revenue that matched Wall Street estimates on Thursday, dented by price declines and a bumpy demand environment.

PALO ALTO, California -- Apple reported record revenues for the October-December period on Thursday, but sales continued to decline in China, where the iPhone maker faces growing competition and a ...

TOKYO -- A tender offer by Singapore-based 3D Investment Partners for NTT Urban Development REIT Investment carries echoes of 2019, when Japan's deeply undervalued REIT market last turned bullish.

CHANGWON, South Korea -- Watching images of raucous street protests in Seoul on his smartphone, author Chun Hyun-woo's eyes ...

MILAN (Reuters) -- Italy's data protection authority said on Thursday it had blocked Chinese artificial intelligence model DeepSeek over a lack of information on its use of personal data.

Normally, there is media fanfare when a film gains international recognition, but this movie remains unreleased in Japan -- not because of a public backlash or censorship, but because of something ...

Although Mitsubishi Chemical Group had planned to build a new U.S. plant for more than a decade, the Japanese manufacturer ultimately walked away from the project due to ballooning costs and a ...

More automotive and aerospace shipments to the U.S. are under scrutiny as officials step up efforts to block imports believed ...

After a year of record profits, Japan's Chugai Pharmaceutical is riding high in the stock market on hopes for an obesity drug under development, but its prospects could be dimmed if Robert F. Kennedy ...